Recently, various therapeutic approaches have been developed for the treatment of DMD [6] including cell transplantation [7], read-through of stop codons [8], gene-addition with micro-dystrophin using adeno-associated virus (AAV) vector [9,10], and exon-skipping [11]. This evidence concerns the gene DMD and Duchenne muscular dystrophy.